2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists

The synthesis of several novel indole melatonin analogues substituted at the 2-position with acylaminomethyl (8 − 11), acylaminoethyl (5a − k), or acylaminopropyl (13) side chains is reported. On the basis of a novel in vitro functional assay (specific binding of [35S]GTPγS), which can discriminate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1998-09, Vol.41 (19), p.3624-3634
Hauptverfasser: Spadoni, Gilberto, Balsamini, Cesarino, Bedini, Annalida, Diamantini, Giuseppe, Di Giacomo, Barbara, Tontini, Andrea, Tarzia, Giorgio, Mor, Marco, Plazzi, Pier Vincenzo, Rivara, Silvia, Nonno, Romolo, Pannacci, Marilou, Lucini, Valeria, Fraschini, Franco, Stankov, Bojidar Michaylov
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The synthesis of several novel indole melatonin analogues substituted at the 2-position with acylaminomethyl (8 − 11), acylaminoethyl (5a − k), or acylaminopropyl (13) side chains is reported. On the basis of a novel in vitro functional assay (specific binding of [35S]GTPγS), which can discriminate agonist from partial agonist, antagonist, and inverse agonist ligands, 5a,g,h,j and 13 were shown to be partial agonists, 5d,e and 8 − 11 competitive antagonists, and 5b,c,k putative inverse agonists. Binding and functional assays were performed on cloned human MT1 receptor. Structure−activity relationship considerations indicate that N-[1-aryl-2-(4-methoxy-1H-indol-2-yl)(C1−C2)alkyl]alkanamides represent a lead structure for this type of ligands.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm970721h